Identifying and validating biomarkers for Alzheimer's disease

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · see citing works

Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease

Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., & Ueland, P. M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1449 · Cited by 1,408 · see citing works

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · see citing works

Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways

Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943 · see citing works

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

Teunissen, C. E., Petzold, A., Bennett, J. L., Berven, F. S., Brundin, L., Comabella, M., Franciotta, D., Frederiksen, J. L., Fleming, J. O., Furlan, R., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c47cc2 · Cited by 845 · see citing works

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

Hampel, H. J., Frank, R., Broich, K., Teipel, S. J., Katz, R. G., Hardy, J., Herholz, K., Bokde, A. L. W., Jessen, F., Hoessler, Y. C., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3115 · Cited by 630 · see citing works

Tau and Aβ42 in Cerebrospinal Fluid from Healthy Adults 21–93 Years of Age: Establishment of Reference Values

Sjögren, M., Vanderstichele, H., Ågren, H., Zachrisson, O., Edsbagge, M., Wikkelsø, C., Skoog, I., Wallin, A., Wahlund, L.-O., Marcusson, J., et al. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.10.1776 · Cited by 436 · see citing works

Healthy Aging and Dementia: Findings from the Nun Study

Snowdon, D. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_2-200309021-00014 · Cited by 412 · see citing works

Telomere shortening in T cells correlates with Alzheimer's disease status

Panossian, L. A. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00043-x · Cited by 409 · see citing works

Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis

Kuo, H., Yen, C., Chang, C., Kuo, C.-K., Chen, J.-H., & Sorond, F. A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70099-5 · Cited by 400 · see citing works

Total and phosphorylated tau protein as biological markers of Alzheimer’s disease

Hampel, H., Blennow, K., Shaw, L. M., Hoessler, Y. C., Zetterberg, H., & Trojanowski, J. Q. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.010 · Cited by 389 · see citing works

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders

Abdi, F. A., Quinn, J. F., Jankovic, J. J., McIntosh, M. W., Leverenz, J. B., Peskind, E. R., Nixon, R., Nutt, J. G., Chung, K., Zabetian, C. P., et al. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9309 · Cited by 385 · see citing works

Short Telomeres in Patients with Vascular Dementia: An Indicator of Low Antioxidative Capacity and a Possible Risk Factor?

von Zglinicki, T., Serra, V., Lorenz, M., Saretzki, G. C., Lenzen-Großimlinghaus, R., Gessner, R. V., Risch, A., & Steinhagen‐Thiessen, E. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780184 · Cited by 305 · see citing works

MicroRNA Expression in Alzheimer Blood Mononuclear Cells

Schipper, H. M., Maes, O. C., Chertkow, H. M., & Wang, E. (2007) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s361 · Cited by 244 · see citing works

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry

Marvin, L., Roberts, M., & Fay, L. B. (2003) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.08.008 · Cited by 226 · see citing works

Imaging and spatial distribution of β-amyloid peptide and metal ions in Alzheimer’s plaques by laser ablation–inductively coupled plasma–mass spectrometry

Hutchinson, R. W., Cox, A. G., McLeod, C. W., Marshall, P. S., Harper, A. J., Dawson, E. L., & Howlett, D. R. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.08.024 · Cited by 189 · see citing works

Proteomic patterns: their potential for disease diagnosis

Xiao, Z., Prieto, D. A., Conrads, T. P., Veenstra, T. D., & Issaq, H. J. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.10.010 · Cited by 187 · see citing works

Transcriptional profiling of Alzheimer blood mononuclear cells by microarray

Maes, O. C., Xu, S., Yu, B., Chertkow, H. M., Wang, E., & Schipper, H. M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.004 · Cited by 182 · see citing works

Blood-Based Biomarkers of Alzheimer's Disease: Challenging but Feasible

Thambisetty, M., & Lovestone, S. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.84 · Cited by 182 · see citing works

Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele

Sunderland, T., Mirza, N., Putnam, K. T., Linker, G., Bhupali, D., Durham, R., Soares, H., Kimmel, L., Friedman, D., Bergeson, J., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.021 · Cited by 179 · see citing works

Biomarkers of aging and disease: Introduction and definitions

Sprott, R. L. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.07.008 · Cited by 179 · see citing works

Measurement of Thirteen Biological Markers in CSF of Patients with Alzheimer’s Disease and Other Dementias

Blasko, I., Lederer, W., OBERBAUER, H., Walch, T., Kemmler, G., Hinterhuber, H., Marksteiner, J., & Humpel, C. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000089137 · Cited by 170 · see citing works

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

Verwey, N. A., van der Flier, W. M., Blennow, K., Clark, C. M., Sokolow, S., Deyn, P. P. D., Galasko, D. R., Hampel, H. J., Hartmann, T., Kapaki, E., et al. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.008232 · Cited by 169 · see citing works

Diagnosis and treatment of Alzheimer’s disease

Desai, A. K., & Grossberg, G. T. (2005) · Neurology · doi:10.1212/wnl.64.12_suppl_3.s34 · Cited by 169 · see citing works

Quantitative analysis of amyloid β peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry

Oe, T., Ackermann, B. L., Inoue, K., Berna, M. J., Garner, C. O., Gelfanova, V., Dean, R. A., Siemers, E., Holtzman, D. M., Farlow, M. R., et al. (2006) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2787 · Cited by 166 · see citing works

Cerebrospinal fluid markers for prediction of Alzheimer's disease

Zetterberg, H., Wahlund, L., & Blennow, K. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.011 · Cited by 162 · see citing works

Konsensusprotokoll zur Standardisierung von Entnahme und Biobanking des Liquor cerebrospinalis1 / A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking

Teunissen, C. E., Petzold, A., Bennett, J. L., Berven, F. S., Brundin, L., Comabella, M., Franciotta, D. M., Federiksen, J. L., Fleming, J. O., Furlan, R., et al. (2010) · Journal of Laboratory Medicine · doi:10.1515/jlm.2010.001 · Cited by 162 · see citing works

Biomarkers for Alzheimer’s disease and other forms of dementia: Clinical needs, limitations and future aspects

Cedazo-Mı́nguez, Á., & Winblad, B. G. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.09.008 · Cited by 156 · see citing works

CSF biomarkers for mild cognitive impairment

Blennow, K. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01368.x · Cited by 151 · see citing works

Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease

Tang, K., Hynan, L. S., Baskin, F., & Rosenberg, R. N. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.09.002 · Cited by 150 · see citing works

Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease

Marksteiner, J., Kemmler, G., Weiss, E. M., Knaus, G., Ullrich, C., Mechtcheriakov, S., OBERBAUER, H., Auffinger, S., Hinterhoelzl, J., Hinterhuber, H., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.011 · Cited by 142 · see citing works

CSF biomarkers for Alzheimer’s disease: use in early diagnosis and evaluation of drug treatment

Blennow, K. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.5.5.661 · Cited by 130 · see citing works

Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: Towards new diagnostic and therapeutic approaches

Wittke, S., Mischak, H., Walden, M., Kölch, W., Rädler, T., & Wiedemann, K. (2005) · Electrophoresis · doi:10.1002/elps.200410140 · Cited by 128 · see citing works

Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease

Hye, A., Kerr, F., Archer, N. J., Foy, C., Poppe, M., Brown, R. G., Hamilton, G., Powell, J. F., Anderton, B. H., & Lovestone, S. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.031 · Cited by 125 · see citing works

Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease

Lukens, J. N., Deerlin, V. M. V., Clark, C. M., Xie, S. X., & Johnson, F. B. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.666 · Cited by 125 · see citing works

Blood-based biomarkers of microvascular pathology in Alzheimer’s disease

Ewers, M., Mielke, M. M., & Hampel, H. J. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.09.005 · Cited by 121 · see citing works

Amyloid β 38, 40, and 42 species in cerebrospinal fluid: More of the same?

Schoonenboom, N. S. M., Mulder, C., van Kamp, G. J., Mehta, S. P., Scheltens, P., Blankenstein, M. A., & Mehta, P. D. (2005) · Annals of Neurology · doi:10.1002/ana.20508 · Cited by 120 · see citing works

Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels

Soares, H. D., Chen, Y., Sabbagh, M. N., Rohrer, A., Schrijvers, E. M. C., & Breteler, M. M. B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05066.x · Cited by 114 · see citing works

Autoantibodies against β‐amyloid are common in Alzheimer's disease and help control plaque burden

Kellner, A., Matschke, J., Bernreuther, C., Moch, H., Ferrer, I., & Glatzel, M. (2009) · Annals of Neurology · doi:10.1002/ana.21475 · Cited by 113 · see citing works

Amyloid β and APP as biomarkers for Alzheimer’s disease

Zetterberg, H., Blennow, K., & Hanse, E. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.08.002 · Cited by 113 · see citing works

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

Simonsen, A., Mcguire, J., Podust, V., Davies, H., Minthon, L., Skoog, I., Andreasen, N., Wallin, A., Waldemar, G., & Blennow, K. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.011 · Cited by 108 · see citing works

Plasma levels of amyloid β-protein 42 are increased in women with mild cognitive impairment

Assini, A., Cammarata, S., Vitali, A., Colucci, M. E. W., Giliberto, L., Borghi, R., Inglese, M. L., Volpe, S., Ratto, S., Dagna-Bricarelli, F., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000137040.64252.ed · Cited by 104 · see citing works

Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study

Lewczuk, P., Kornhuber, J., Vanderstichele, H., Vanmechelen, E., Esselmann, H., Bibl, M., Wolf, S., Otto, M., Reulbach, U., Kölsch, H., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.010 · Cited by 95 · see citing works

Biomarkers for neurodegenerative diseases

Henley, S. M. D., Bates, G. P., & Tabrizi, S. J. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000186842.51129.cb · Cited by 90 · see citing works

Brain ubiquitin is markedly elevated in Alzheimer disease

Wang, G. P., Khatoon, S., Iqbal, K., & Grundke, I. (1991) · Brain Research · doi:10.1016/0006-8993(91)91692-t · Cited by 89 · see citing works

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers.

Sjögren, M., Andreasen, N., & Blennow, K. (2003) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/s0009-8981(03)00121-9 · Cited by 88 · see citing works

Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets

Borroni, B., Agosti, C., Marcello, E. E., Luca, M. D., & Padovani, A. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.08.004 · Cited by 88 · see citing works

Single cell gene expression profiling in Alzheimer’s disease

Ginsberg, S. D., Che, S., Counts, S., & Mufson, E. J. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.05.007 · Cited by 76 · see citing works

Alzheimer disease: correlation of cerebro-spinal fluid and brain ubiquitin levels

Kudo, T., Iqbal, K., Ravid, R., Swaab, D. F., & Grundke, I. (1994) · Brain Research · doi:10.1016/0006-8993(94)91757-4 · Cited by 75 · see citing works

Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer’s disease

Leuner, K., Pantel, J., Frey, C., Schindowski, K., Schulz, K. L., Wegat, T., Maurer, K., Eckert, A., & Müller, W. E. G. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_27 · Cited by 74 · see citing works

Cerebrospinal Fluid Profile of Amyloid β Peptides in Patients with Alzheimer’s Disease Determined by Protein Biochip Technology

Maddalena, A. S., Papassotiropoulos, A., Gonzalez-Agosti, C., Signorell, A., Hegi, T., Pasch, T., Nitsch, R. M., & Höck, C. (2004) · Neurodegenerative Diseases · doi:10.1159/000080991 · Cited by 74 · see citing works

Decreased β-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration

Noguchi, M., Yoshita, M., Matsumoto, Y., Ono, K., Iwasa, K., & Yamada, M. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.05.015 · Cited by 72 · see citing works

Decreased serum amyloid β1–42 autoantibody levels in Alzheimer’s disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β1–42 peptide

Brettschneider, S., Morgenthaler, N. G., Teipel, S. J., Fischer-Schulz, C., Bürger, K., Dodel, R. C., Du, Y., Möller, H., Bergmann, A., & Hampel, H. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.008 · Cited by 70 · see citing works

AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis

Stefani, A., Bernardini, S., Panella, M., Pierantozzi, M., Nuccetelli, M., Koch, G., Urbani, A., Giordano, A., Martorana, A., Orlacchio, A., et al. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.05.016 · Cited by 63 · see citing works

Gene Expression as Peripheral Biomarkers for Sporadic Alzheimer's Disease

Grünblatt, E., Bartl, J., Zehetmayer, S., Ringel, T. M., Bauer, P., Riederer, P. F., & Jacob, C. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0996 · Cited by 59 · see citing works

Growth factors and cytokines/chemokines as surrogate biomarkers in cerebrospinal fluid and blood for diagnosing Alzheimer’s disease and mild cognitive impairment

Olson, L., & Humpel, C. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.011 · Cited by 57 · see citing works

Unfolded p53: A Potential Biomarker for Alzheimer's Disease

Lanni, C., Uberti, D. L., Racchi, M., Govoni, S. M., & Memo, M. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12109 · Cited by 55 · see citing works

Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid(1-42), tau, phospho-tau-181 and total protein

Marksteiner, J., Hinterhuber, H., & Hinterhuber, C. (2007) · Drugs of today · doi:10.1358/dot.2007.43.6.1067341 · Cited by 52 · see citing works

Increased CSF levels of nerve growth factor in patients with Alzheimer’s disease

Hock, C., Heese, K., Müller-Spahn, F., Huber, P., Riesen, W., Nitsch, R. M., & Otten, U. (2000) · Neurology · doi:10.1212/wnl.54.10.2009 · Cited by 52 · see citing works

Predicting Alzheimer dementia in mild cognitive impairment patients

Borroni, B., Luca, M. D., & Padovani, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.023 · Cited by 51 · see citing works

Soluble cell adhesion molecules in monocytes of Alzheimer’s disease and mild cognitive impairment

Hochstrasser, T., Weiss, E. M., Marksteiner, J., & Humpel, C. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.005 · Cited by 49 · see citing works

Biomarkers for apoptosis in Alzheimer's disease

Ankarcrona, M., & Winblad, B. G. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1260 · Cited by 46 · see citing works

Plasma amyloid β protein 42 in non-demented persons aged 75 years: Effects of concomitant medication and medial temporal lobe atrophy

Blasko, I., Kemmler, G., Krampla, W. W., Jungwirth, S., Wichart, I., Jellinger, K. A., Tragl, K. H., & Fischer, P. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.006 · Cited by 46 · see citing works

Biomarkers of inflammation and amyloid-β phagocytosis in patients at risk of Alzheimer disease

Fiala, M., & Veerhuis, R. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.08.003 · Cited by 45 · see citing works

Protein kinase C as a peripheral biomarker for Alzheimer’s disease

de Barry, J., Mbebi, C., & Janoshazi, A. K. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.015 · Cited by 45 · see citing works

Increased caspase activation in peripheral blood mononuclear cells of patients with Alzheimer's disease

Tacconi, S., Perri, R., Balestrieri, E., Grelli, S., Bernardini, S., Annichiarico, R., Mastino, A., Caltagirone, C., & Macchi, B. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.07.009 · Cited by 44 · see citing works

Ubiquitin–proteasome pathway is compromised in CD45RO+ and CD45RA+ T lymphocyte subsets during aging

Ponnappan, U. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00203-0 · Cited by 41 · see citing works

Apoptosis of CD4+ T and Natural Killer Cells in Alzheimer's Disease

Schindowski, K., Peters, J., Gorriz, C., Schramm, U., Weinandi, T., Leutner, S., Maurer, K., Frölich, L., Müller, W. E. G., & Eckert, A. (2006) · Pharmacopsychiatry · doi:10.1055/s-2006-954591 · Cited by 39 · see citing works

Dissociated amyloid-β antibody levels as a serum biomarker for the progression of Alzheimer’s disease: A population-based study

Gustaw‐Rothenberg, K., Siedlak, S. L., Bonda, D., Lerner, A. J., Tabaton, M., Perry, G. L., & Smith, M. A. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.003 · Cited by 39 · see citing works

Alzheimer’s disease biomarker discovery in symptomatic and asymptomatic patients: Experimental approaches and future clinical applications

Ho, L., Fivecoat, H. C., Wang, J., & Pasinetti, G. M. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.09.007 · Cited by 37 · see citing works

Problems Associated with Biological Markers of Alzheimer’s Disease

Frey, H. J., Mattila, K. M., Korolainen, M. A., & Pirttilä, T. (2005) · Neurochemical Research · doi:10.1007/s11064-005-8827-7 · Cited by 36 · see citing works

Telomeres

Baird, D. M. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.09.009 · Cited by 30 · see citing works

Ubiquitin Enzymes, Ubiquitin and Proteasome Activity in Blood Mononuclear Cells of MCI, Alzheimer and Parkinson Patients

Ullrich, C., Mlekusch, R., Kuschnig, A., Marksteiner, J., & Humpel, C. (2010) · Current Alzheimer Research · doi:10.2174/156720510792231766 · Cited by 29 · see citing works

Are Peripheral Blood Cells From Patients With Alzheimer Disease More Sensitive to Apoptotic Stimuli?

Bergman, M., Salman, H., Beloosesky, Y., Djaldetti, M., & Bessler, H. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200207000-00005 · Cited by 26 · see citing works

Immuno-PCR-based quantification of multiple phosphorylated tau-epitopes linked to Alzheimer’s disease

Singer, D. L., Soininen, H. S., Alafuzoff, I. I., & Hoffmann, R. (2009) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-009-3208-8 · Cited by 21 · see citing works

Glycogen-synthase kinase-3β is decreased in peripheral blood mononuclear cells of patients with mild cognitive impairment

Marksteiner, J., & Humpel, C. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.02.007 · Cited by 16 · see citing works

[P‐019]: Plasma amyloid beta protein 42 in non‐demented persons aged 75‐years: Effects of concomitant medication and medial temporal lobe atrophy

Blasko, I., Kemmler, J., Krampla, W. W., Jungwirt, S., Wichard, I., Jellinger, K. A., Tragl, K. H., & Fischer, P. A. (2005) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.06.081 · Cited by 15 · see citing works

Serum Amyloid Beta Peptides in Patients with Dementia and Age-Matched Non-Demented Controls as Detected by Surface-Enhanced Laser Desorption Ionisation-Time of Flight Mass Spectrometry (SELDI-TOF MS)

Frankfort, S. V., van Campen, J., Tulner, L. R., & Beijnen, J. H. (2008) · Current Clinical Pharmacology · doi:10.2174/157488408785747665 · Cited by 11 · see citing works

MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix‐assisted laser desorption/ionization time‐of‐flight tandem mass spectrometry based targeted quantitative proteomics platform

Oh, J. H., Pan, S., Zhang, J., & Gao, J. (2010) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.4407 · Cited by 8 · see citing works

The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization

Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 881 · see citing works

Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease

Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820 · see citing works

Circulating miRNA Biomarkers for Alzheimer's Disease

Kumar, P., Dezső, Z., MacKenzie, C. J., Oestreicher, J., Agoulnik, S. I., Byrne, M., Bernier, F., Yanagimachi, M., Aoshima, K., & Oda, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069807 · Cited by 386 · see citing works

Advances in the development of biomarkers for epilepsy

Pitkänen, A., Löscher, W., Vezzani, A., Becker, A. J., Simonato, M., Łukasiuk, K., Gröhn, O. H. J., Bankstahl, J. P., Friedman, A., Aronica, E., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00112-5 · Cited by 370 · see citing works

Recent Advances in 2D Material Theory, Synthesis, Properties, and Applications

Lin, Y., Torsi, R., Younas, R., Hinkle, C. L., Rigosi, A. F., Hill, H. M., Zhang, K., Huang, S., Shuck, C. E., Chen, C., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c12759 · Cited by 354 · see citing works

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

Lewczuk, P., Riederer, P. F., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramı́rez, A., Parnetti, L., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 308 · see citing works

Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment

Folch, J., Petrov, D., Ettcheto, M., Abad, S., Sánchez-López, E., García, M. L., Olloquequi, J., Beas-Zarate, C., Auladell, C., & Camins, A. (2016) · Neural Plasticity · doi:10.1155/2016/8501693 · Cited by 270 · see citing works

microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF).

(2012) · PubMed Central · Cited by 248 · see citing works

INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES

Baru, P. C. R. (2014) · ADVANCED SCIENCES INDEX · Cited by 236 · see citing works

Functional Foods and Nutraceuticals as Dietary Intervention in Chronic Diseases; Novel Perspectives for Health Promotion and Disease Prevention

Adefegha, S. A. (2017) · Journal of Dietary Supplements · doi:10.1080/19390211.2017.1401573 · Cited by 226 · see citing works

Raman Spectroscopy: An Emerging Tool in Neurodegenerative Disease Research and Diagnosis

Devitt, G., Howard, K., Mudher, A. K., & Mahajan, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00413 · Cited by 208 · see citing works

Increased White Matter Inflammation in Aging- and Alzheimer’s Disease Brain

Raj, D., Yin, Z., Breur, M., Doorduin, J., Holtman, I. R., Olah, M., Mantingh-Otter, I. J., Van Dam, D., De Deyn, P. P., den Dunnen, W., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00206 · Cited by 180 · see citing works

Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives

McGrowder, D. A., Miller, F. G., Vaz, K., Nwokocha, C. R., Wilson-Clarke, C. F., Anderson, M., Brown, J., Anderson-Jackson, L., Williams, L., Latore, L., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11020215 · Cited by 167 · see citing works

Differential diagnosis of Alzheimer’s disease using spectrochemical analysis of blood

Paraskevaidi, M., Morais, C. L. M., Lima, K. M. G., Snowden, J. S., Saxon, J. A., Richardson, A. M. T., Jones, M. S., Mann, D. M. A., Allsop, D., Martin‐Hirsch, P. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701517114 · Cited by 163 · see citing works

Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease

Marksteiner, J., Blasko, I., Kemmler, G., Koal, T., & Humpel, C. (2017) · Metabolomics · doi:10.1007/s11306-017-1297-5 · Cited by 158 · see citing works

Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer’s Disease: Potential and Limitations

Cosín‐Tomás, M., Antonell, A., Lladó, A., Alcolea, D. A., Fortea, J., Ezquerra, M., Lleó, A., Martı́, M. J., Pallàs, M., Sánchez‐Valle, R., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0088-8 · Cited by 157 · see citing works

Progressive dysexecutive syndrome due to Alzheimer's disease: a description of 55 cases and comparison to other phenotypes

Townley, R. A., Graff-Radford, J., Mantyh, W. G., Botha, H., Polsinelli, A. J., Przybelski, S. A., Machulda, M. M., Makhlouf, A. T., Senjem, M. L., Murray, M. E., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa068 · Cited by 145 · see citing works

Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease

Rotman, M., Welling, M. M., Bunschoten, A., de Backer, M. E., Rip, J., Nabuurs, R. J. A., Gaillard, P. J., van Buchem, M. A., van der Maarel, S. M., & van der Weerd, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.012 · Cited by 152 · see citing works

The diagnostic value of FDG and amyloid PET in Alzheimer’s disease—A systematic review

Rice, L., & Bisdas, S. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.07.014 · Cited by 150 · see citing works

Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?

Bell, S., Barnes, K., Marco, M. D., Shaw, P. J., Ferraiuolo, L., Blackburn, D. J., Venneri, A., & Mortiboys, H. (2021) · Biomedicines · doi:10.3390/biomedicines9010063 · Cited by 136 · see citing works

Biosensors for Alzheimer's disease biomarker detection: A review

Shui, B., Tao, D., Florea, A., Cheng, J., Zhao, Q., Gu, Y., Li, W., Jaffrezic-Renault, N. J., Mei, Y., & Guo, Z. (2018) · Biochimie · doi:10.1016/j.biochi.2017.12.015 · Cited by 136 · see citing works

Retinal imaging in Alzheimer’s disease

Cheung, C. Y.-L., Mok, V., Foster, P. J., Trucco, E., Chen, C., & Wong, T. Y. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325347 · Cited by 134 · see citing works

Animal models of Alzheimer disease: historical pitfalls and a path forward

Cavanaugh, S. E. (2014) · ALTEX · doi:10.14573/altex.1310071 · Cited by 132 · see citing works

When Does Alzheimer′s Disease Really Start? The Role of Biomarkers

Lloret, A., Esteve, D., Lloret, M.-A., Cervera-Ferri, A., Lopez, B., Nepomuceno, M., & Monllor, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225536 · Cited by 131 · see citing works

Telomere length is age-dependent and reduced in monocytes of Alzheimer patients

Hochstrasser, T., Marksteiner, J., & Humpel, C. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.11.012 · Cited by 132 · see citing works

Raman spectroscopy and machine learning for biomedical applications: Alzheimer’s disease diagnosis based on the analysis of cerebrospinal fluid

Ryzhikova, E., Ralbovsky, N. M., Sikirzhytski, V., Kazakov, O., Halámková, L., Quinn, J. F., Zimmerman, E. A., & Lednev, I. K. (2020) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2020.119188 · Cited by 131 · see citing works

Neurotheranostics as Personalized Medicines

Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124 · see citing works

Molecular and cellular pathophysiology of preclinical Alzheimer’s disease

Mufson, E. J., Ikonomović, M. D., Counts, S., Perez, S. E., Malek‐Ahmadi, M. H., Scheff, S. W., & Ginsberg, S. D. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.030 · Cited by 129 · see citing works

A Review of Fermented Foods with Beneficial Effects on Brain and Cognitive Function

Kim, B., Hong, V. M., Yang, J., Hyun, H., Im, J. J., Hwang, J., Yoon, S. J., & Kim, J. E. (2016) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2016.21.4.297 · Cited by 128 · see citing works

Biofunctionalized Magnetic Nanoparticles for Specifically Detecting Biomarkers of Alzheimer’s Disease in Vitro

Yang, C., Yang, S., Chieh, J.-J., Horng, H. E., Hong, C., Yang, H.-C., Chen, K. H., Shih, B.-Y., Chen, T., & Chiu, M. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200028j · Cited by 123 · see citing works

Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer's Disease: Methodology and Baseline Sample Characteristics

Byun, M. S., Yi, D., Lee, J. H., Choe, Y. M., Sohn, B. K., Lee, J., Choi, H. J., Baek, H., Kim, Y. K., Lee, Y., et al. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.6.851 · Cited by 116 · see citing works

Current applications of antibody microarrays

Chen, Z., Dodig‐Crnković, T., Schwenk, J. M., & Tao, S. (2018) · Clinical Proteomics · doi:10.1186/s12014-018-9184-2 · Cited by 121 · see citing works

Surface plasmon resonance biosensors for detection of Alzheimer's biomarkers; an effective step in early and accurate diagnosis

Rezabakhsh, A., Rahbarghazi‬, R., & Fathi, F. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112511 · Cited by 120 · see citing works

Close Correlation of Monoamine Oxidase Activity with Progress of Alzheimer’s Disease in Mice, Observed by in Vivo Two-Photon Imaging

Kim, D., Baik, S. H., Kang, S., Cho, S. W., Bae, J., Cha, M.-Y., Sailor, M. J., Mook‐Jung, I., & Ahn, K. H. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00309 · Cited by 112 · see citing works

MicroRNA in Alzheimer’s disease: an exploratory study in brain, cerebrospinal fluid and plasma

Bekris, L. M., Lutz, F., Montine, T. J., Yu, C., Tsuang, D. W., Peskind, E. R., & Leverenz, J. B. (2013) · Biomarkers · doi:10.3109/1354750x.2013.814073 · Cited by 112 · see citing works

The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment

Klavins, K., Koal, T., Dallmann, G., Marksteiner, J., Kemmler, G., & Humpel, C. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.05.003 · Cited by 110 · see citing works

Brain-age is associated with progression to dementia in memory clinic patients

Biondo, F., Jewell, A., Pritchard, M., Aarsland, D., Steves, C. J., Mueller, C., & Cole, J. H. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103175 · Cited by 110 · see citing works

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid

Huynh, R. A., & Mohan, C. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00102 · Cited by 109 · see citing works

Biomarkers in Sporadic and Familial Alzheimer’s Disease

Lista, S., O’Bryant, S. E., Blennow, K., Dubois, B., Hugon, J., Zetterberg, H., & Hampel, H. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143006 · Cited by 106 · see citing works

Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer’s Disease

Tzen, K., Yang, S., Chen, T., Cheng, T.-W., Horng, H. E., Wen, H.-P., Huang, Y.-Y., Shiue, C., & Chiu, M. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500101j · Cited by 103 · see citing works

Cascaded multi-modal mixing transformers for Alzheimer’s disease classification with incomplete data

Liu, L., Liu, S., Zhang, L., To, X. V., Nasrallah, F., & Chandra, S. S. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120267 · Cited by 101 · see citing works

Identification of Differentially Expressed Genes through Integrated Study of Alzheimer’s Disease Affected Brain Regions

Puthiyedth, N., Riveros, C., Berretta, R. E., & Moscato, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152342 · Cited by 103 · see citing works

Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease

García-Morales, V., González-Acedo, A., Melguizo-Rodríguez, L., Pardo-Moreno, T., Costela-Ruiz, V. J., Montiel-Troya, M., & Ramos-Rodríguez, J. J. (2021) · Biomedicines · doi:10.3390/biomedicines9121910 · Cited by 104 · see citing works

Repetitive head impact exposure and later‐life plasma total tau in former National Football League players

Alosco, M. L., Tripodis, Y., Jarnagin, J., Baugh, C. M., Martin, B. M., Chaisson, C. E., Estochen, N., Song, L., Cantu, R. C., Jeromin, A., et al. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.11.003 · Cited by 100 · see citing works

Chemical sensing platforms for detecting trace-level Alzheimer's core biomarkers

Kim, K., Lee, C. H., & Park, C. B. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00107d · Cited by 101 · see citing works

Sphingomyelin SM(d18:1/18:0) is Significantly Enhanced in Cerebrospinal Fluid Samples Dichotomized by Pathological Amyloid-β 42 , Tau, and Phospho-Tau-181 Levels

Koal, T., Klavins, K., Seppi, D., Kemmler, G., & Humpel, C. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142319 · Cited by 98 · see citing works

Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases

Vanda, D., Zajdel, P., & Soural, M. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111569 · Cited by 97 · see citing works

Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function

Mak, A. C. Y., Pullinger, C. R., Tang, L. F., Wong, J. S., Deo, R. C., Schwarz, J.-M., Gugliucci, A., Movsesyan, I., Ishida, B. Y., Chu, C., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2011 · Cited by 96 · see citing works

Recent trends in analytical approaches for detecting neurotransmitters in Alzheimer's disease

Sangubotla, R., & Kim, J. (2018) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.05.014 · Cited by 95 · see citing works

Biosensors for detection of Tau protein as an Alzheimer's disease marker

Ameri, M., Shabaninejad, Z., Movahedpour, A., Sahebkar, A., Mohammadi, S., Hosseindoost, S., Ebrahimi, M. S., Savardashtaki, A., Karimipour, M., & Mirzaei, H. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.239 · Cited by 95 · see citing works

Amylin Uncovered: A Review on the Polypeptide Responsible for Type II Diabetes

Pillay, K., & Govender, P. (2013) · BioMed Research International · doi:10.1155/2013/826706 · Cited by 94 · see citing works

Plasma biomarkers predict Alzheimer’s disease before clinical onset in Chinese cohorts

Cai, H., Pang, Y., Fu, X., Ren, Z., & Jia, L. (2023) · Nature Communications · doi:10.1038/s41467-023-42596-6 · Cited by 92 · see citing works

Raman Spectroscopy to Diagnose Alzheimer’s Disease and Dementia with Lewy Bodies in Blood

Paraskevaidi, M., Morais, C. L. M., Halliwell, D. E., Mann, D. M. A., Allsop, D., Martin‐Hirsch, P. L., & Martin, F. L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00198 · Cited by 90 · see citing works

The MiRNA Journey from Theory to Practice as a CNS Biomarker

Stoicea, N., Du, A., Lakis, D. C., Tipton, C. B., Arias-Morales, C. E., & Bergese, S. D. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00011 · Cited by 89 · see citing works

Amyloid-beta and depression in healthy older adults: A systematic review

Harrington, K., Lim, Y. Y., Gould, E., & Maruff, P. T. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414557161 · Cited by 88 · see citing works

Exploring Biomarkers for Alzheimer’s Disease

Sharma, N. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/18828.8166 · Cited by 86 · see citing works

Protein microarray technology: how far off is routine diagnostics?

Cretich, M., Damin, F., & Chiari, M. (2013) · The Analyst · doi:10.1039/c3an01619f · Cited by 85 · see citing works

A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1–42 peptide in human plasma with utility for studies of Alzheimer’s disease therapeutics

Song, L., Lachno, D. R., Hanlon, D., Shepro, A., Jeromin, A., Gemani, D., Talbot, J. A., Racke, M. M., Dage, J. L., & Dean, R. A. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0225-7 · Cited by 85 · see citing works

Complexity Measures for Quantifying Changes in Electroencephalogram in Alzheimer’s Disease

Al-Nuaimi, A. H. H., Jammeh, E., Sun, L., & Ifeachor, E. (2018) · Complexity · doi:10.1155/2018/8915079 · Cited by 82 · see citing works

Olfactory Dysfunction as a Global Biomarker for Sniffing out Alzheimer’s Disease: A Meta-Analysis

Kotecha, A., Corrêa, A., Fisher, K., & Rushworth, J. V. (2018) · Biosensors · doi:10.3390/bios8020041 · Cited by 82 · see citing works

Toward sensitive immuno-based detection of tau protein by surface plasmon resonance coupled to carbon nanostructures as signal amplifiers

Lisi, S., Scarano, S., Fedeli, S., Pascale, E., Cicchi, S., Ravelet, C., Peyrin, É., & Minunni, M. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.08.078 · Cited by 81 · see citing works

A Comprehensive Report on Machine Learning-based Early Detection of Alzheimer's Disease using Multi-modal Neuroimaging Data

Sharma, S., & Mandal, P. K. (2022) · ACM Computing Surveys · doi:10.1145/3492865 · Cited by 86 · see citing works

Changes in plasma and cerebrospinal fluid biomarkers in aged patients with early postoperative cognitive dysfunction following total hip-replacement surgery

Ji, M., Yuan, H., Zhang, G.-F., Li, X., Dong, L., Li, W., Zhou, Z., & Yang, J. (2012) · Journal of Anesthesia · doi:10.1007/s00540-012-1506-3 · Cited by 78 · see citing works

Development of a high-sensitivity immunoassay for amyloid-beta 1–42 using a silicon microarray platform

Gagni, P., Solá, L., Cretich, M., & Chiari, M. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.03.077 · Cited by 78 · see citing works

Role of Hemichannels in CNS Inflammation and the Inflammasome Pathway

Kim, Y., Davidson, J. O., Gunn, K. C., Phillips, A. R. J., Green, C. R., & Gunn, A. J. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.12.001 · Cited by 75 · see citing works

Recent advances in optical biosensing approaches for biomarkers detection

Akgönüllü, S., & Deni̇zli̇, A. (2022) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2022.100269 · Cited by 75 · see citing works

Serum d-serine levels are altered in early phases of Alzheimer’s disease: towards a precocious biomarker

Piubelli, L., Pollegioni, L., Rabattoni, V., Mauri, M. F., Cariddi, L. P., Versino, M., & Sacchi, S. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01202-3 · Cited by 74 · see citing works

Cholinesterases as Biomarkers for Parasympathetic Dysfunction and Inflammation-Related Disease

Shenhar‐Tsarfaty, S., Berliner, S., Bornstein, N. M., & Soreq, H. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0176-4 · Cited by 73 · see citing works

Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling

Adav, S. S., & Sze, S. K. (2016) · Molecular Brain · doi:10.1186/s13041-016-0272-9 · Cited by 72 · see citing works

Multifunctional soft implants to monitor and control neural activity in the central and peripheral nervous system: A review

Fekete, Z., & Pongracz, A. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.12.096 · Cited by 72 · see citing works

Non-invasive screening for early Alzheimer’s disease diagnosis by a sensitively immunomagnetic biosensor

Li, S., Lin, C.-W., Wei, K., Huang, C.-Y., Hsu, P., Liu, H.-L., Lin, Y.-J., Lin, S.-C., Yang, H., & Ma, C.-C. M. (2016) · Scientific Reports · doi:10.1038/srep25155 · Cited by 70 · see citing works

Role of milk and dairy intake in cognitive function in older adults: a systematic review and meta-analysis

Lee, J., Fu, Z., Chung, M. C., Jang, D.-J., & Lee, H. (2018) · Nutrition Journal · doi:10.1186/s12937-018-0387-1 · Cited by 71 · see citing works

Gene therapy for neurological disorders

Choong, C., Baba, K., & Mochizuki, H. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1114096 · Cited by 69 · see citing works

Antibody-based magnetic nanoparticle immunoassay for quantification of Alzheimer’s disease pathogenic factor

Kim, C.-B., Choi, Y. Y., Song, W. K., & Song, K. (2013) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.5.051205 · Cited by 66 · see citing works

Recent advances in biosensors for neurodegenerative disease detection

Ganesh, H. V. S., Chow, A. M., & Kerman, K. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2016.02.012 · Cited by 68 · see citing works

Single-step immunoassays and microfluidic droplet operation: Towards a versatile approach for detection of amyloid-β peptide-based biomarkers of Alzheimer’s disease

Mai, T. D., Ferraro, D., Aboud, N., Renault, R., Serra, M., Tran, N. T., Viovy, J., Smadja, C., Descroix, S., & Taverna, M. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.09.003 · Cited by 68 · see citing works

Is Sleep Disruption a Cause or Consequence of Alzheimer’s Disease? Reviewing Its Possible Role as a Biomarker

Lloret, M.-A., Cervera-Ferri, A., Nepomuceno, M., Monllor, P., Esteve, D., & Lloret, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031168 · Cited by 68 · see citing works

Spectroscopic imaging with spectral domain visible light optical coherence microscopy in Alzheimer’s disease brain samples

Lichtenegger, A., Harper, D. J., Augustin, M., Eugui, P., Muck, M., Gesperger, J., Hitzenberger, C. K. F., Wöehrer, A., & Baumann, B. (2017) · Biomedical Optics Express · doi:10.1364/boe.8.004007 · Cited by 67 · see citing works

Advances in Multi-Functional Ligands and the Need for Metal-Related Pharmacology for the Management of Alzheimer Disease

Sharma, A., Pachauri, V., & Flora, S. J. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01247 · Cited by 67 · see citing works

Competitive electrochemical immunosensor for the detection of unfolded p53 protein in blood as biomarker for Alzheimer’s disease

Amor-Gutiérrez, O., Costa‐Rama, E., Varas, N. A., Martínez-Rodríguez, C., Novelli, A., Fernández‐Sánchez, M. T., & Costa‐García, A. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.09.042 · Cited by 67 · see citing works

Early diagnosis of Alzheimer's disease using infrared spectroscopy of isolated blood samples followed by multivariate analyses

Mordechai, S., Shufan, E., Katz, B. S. P., & Salman, A. (2016) · The Analyst · doi:10.1039/c6an01580h · Cited by 66 · see citing works

Non-SELEX isolation of DNA aptamers for the homogeneous-phase fluorescence anisotropy sensing of tau Proteins

Lisi, S., Fiore, E., Scarano, S., Pascale, E., Boehman, Y., Ducongè, F., Chierici, S., Minunni, M., Peyrin, É., & Ravelet, C. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.07.029 · Cited by 66 · see citing works

Detecting Alzheimer's disease biomarkers: From antibodies to new bio-mimetic receptors and their application to established and emerging bioanalytical platforms – A critical review

Scarano, S., Lisi, S., Ravelet, C., Peyrin, É., & Minunni, M. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.08.008 · Cited by 65 · see citing works

Dynamic brain fluctuations outperform connectivity measures and mirror pathophysiological profiles across dementia subtypes: A multicenter study

Moguilner, S., García, A. M., Perl, Y. S., Tagliazucchi, E., Piguet, O., Kumfor, F., Reyes, P., Matallana, D., Sedeño, L., & Ibáñez, A. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2020.117522 · Cited by 63 · see citing works

Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases

Giacomelli, C., Daniele, S., & Martini, C. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.017 · Cited by 64 · see citing works

BACE1 as a Potential Biomarker for Alzheimer's Disease

Decourt, B., & Sabbagh, M. N. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110017 · Cited by 61 · see citing works

¹⁸ F-FDG PET for Prediction of Conversion to Alzheimer’s Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy

Smailagic, N., Lafortune, L., Kelly, S., Hyde, C., & Brayne, C. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171125 · Cited by 61 · see citing works

Highly sensitive surface-enhanced Raman scattering-based immunosensor incorporating half antibody-fragment for quantitative detection of Alzheimer's disease biomarker in blood

Yang, S. J., Lee, J. U., Jeon, M. J., & Sim, S. J. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.339445 · Cited by 59 · see citing works

Blood-based biomarkers of cerebral small vessel disease

Wu, L., Chai, Y. L., Cheah, I. K.-M., Chia, R. S. L., Hilal, S., Arumugam, T. V., Chen, C., & Lai, M. K. P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102247 · Cited by 62 · see citing works

Detection of Aβ Monomers and Oligomers: Early Diagnosis of Alzheimer's Disease

Zhou, Y., Liu, L., Hao, Y., & Xu, M. (2016) · Chemistry - An Asian Journal · doi:10.1002/asia.201501355 · Cited by 61 · see citing works

Clinical applications of MALDI imaging technologies in cancer and neurodegenerative diseases

Uçal, Y., Durer, Z. A. O., Atak, H., Kadioglu, E., Şahin, B., Coşkun, A., Baykal, A. T., & Özpınar, A. (2017) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2017.01.005 · Cited by 57 · see citing works

Evaluating the reliability of neurocognitive biomarkers of neurodegenerative diseases across countries: A machine learning approach

Bachli, M. B., Sedeño, L., Ochab, J. K., Piguet, O., Kumfor, F., Reyes, P., Torralva, T., Roca, M., Cardona, J. F., Campo, C. G., et al. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2019.116456 · Cited by 57 · see citing works

Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future

Karaboğa, M. N. S., & Sezgintürk, M. K. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114479 · Cited by 58 · see citing works

Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer’s disease

Xu, X., Huang, Y. M., Wang, G., & Chen, S. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1272-0 · Cited by 57 · see citing works

Increased Acetylation of Histone H4 at Lysine 12 (H4K12) in Monocytes of Transgenic Alzheimer’s Mice and in Human Patients

Plagg, B., Ehrlich, D., Kniewallner, K. M., Marksteiner, J., & Humpel, C. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150710114256 · Cited by 58 · see citing works

Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer’s Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment

Leko, M. B., Borovečki, F., Dejanović, N., Hof, P. R., & Šimić, G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150705 · Cited by 56 · see citing works

Tackling variability: a multicenter study to provide a gold-standard network approach for frontotemporal dementia

Sedeño, L., Piguet, O., Abrevaya, S., Desmaras, H., García‐Cordero, I., Baez, S., Alethia de la Fuente, L., Reyes, P., Tu, S., Moguilner, S., et al. (2017) · Human Brain Mapping · doi:10.1002/hbm.23627 · Cited by 55 · see citing works

Epilepsy and its neurobehavioral comorbidities: Insights gained from animal models

Löscher, W., & Stafstrom, C. E. (2022) · Epilepsia · doi:10.1111/epi.17433 · Cited by 61 · see citing works

A review of neuroimaging biomarkers of Alzheimer's disease.

Varghese, T., Sheelakumari, R., James, J. S., & Mathuranath, P. S. (2013) · PubMed · Cited by 55 · see citing works

Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer’s disease diagnosis

Murakami, K., Tokuda, M., Suzuki, T., Irie, Y., Hanaki, M., Izuo, N., Monobe, Y., Akagi, K., Ishii, R., Tatebe, H., et al. (2016) · Scientific Reports · doi:10.1038/srep29038 · Cited by 55 · see citing works

Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid(1-42), tau, phospho-tau-181 and total protein

Marksteiner, J., Hinterhuber, H., & Hinterhuber, C. (2007) · Drugs of today · doi:10.1358/dot.2007.43.6.1067341 · Cited by 52 · see citing works

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers.

Sjögren, M., Andreasen, N., & Blennow, K. (2003) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/s0009-8981(03)00121-9 · Cited by 88 · see citing works

Cerebrospinal fluid and blood biomarkers in Alzheimer’s disease

Humpel, C. (2011) · World Journal of Psychiatry · doi:10.5498/wjp.v1.i1.8 · Cited by 51 · see citing works

The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer’s Disease

Engelborghs, S., & Bastard, N. L. (2012) · Molecular Diagnosis & Therapy · doi:10.1007/bf03262201 · Cited by 20 · see citing works

Marking the markers of Alzheimer's: too good to diagnose, too bad to use?

Galik-Olah, Z., Pákáski, M., Janka, Z., & Kalman, J. L. (2012) · PubMed · Cited by 2 · see citing works